Latest News

Epilepsy community seeks redefinition of bioequivalence from FDA

For several years, epilepsy practitioners have questioned the U.S. Food and Drug Administration?s (FDA) definition of bioequivalence as it applies to narrow therapeutic index (NTI) drugs, such as those used for epilepsy. In response to these concerns, the FDA has sponsored 3 studies of antiepileptic drugs and also convened an advisory board to help determine which drugs are NTI.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Patterns of brain activity reorganize visual perception during eye movements

  • 'Pain sensing' gene discovery could help in development of new methods of pain relief

  • Special fats proven essential for brain growth

  • Earthquakes prove to be an unexpected help in interpreting brain activity of very premature babies

  • Can you see what I hear? Blind human echolocators use visual areas of the brain

  • Depression associated with 5-fold increased mortality risk in heart failure patients

  • Rates of re-hospitalization for patients with traumatic brain injury higher than previously reported

  • Parents are integral in stopping rise as teen e-cigarette usage triples

  • Anti-stroke drug effective treatment for middle-ear infections, researchers say

  • Implantable micro-device to monitor oxygen in glioma to improve treatment outcomes

  •